The interplay between hMLH1 and hMRE11: Role in MMR and the effect of hMLH1 mutations

Nianxi Zhao, Fengxue Zhu, Fenghua Yuan, Anoria K. Haick, Shinichi Fukushige, Liya Gu, Chengtao Her

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Our previous studies indicate that hMRE11 plays a role in MMR, and this function of hMRE11 is most likely mediated by the hMLH1-hMRE11 interaction. Here, we explored the functional implications of the hMLH1-hMRE11 interaction in MMR and the effects of hMLH1 mutations on their interaction. Our in vitro MMR assay demonstrated that the dominant-negative hMRE11452-634 mutant peptide (i.e., harboring only the hMLH1-interacting domain) imparted a significant reduction in both 3′ excision and 3′-directed MMR activities. Furthermore, the expression of hMRE11452-634, and to a lesser extent hMRE111-634 (ATLD1), impaired G2/M checkpoint control in response to MNU and cisplatin treatments, rendering cells resistant to killings by these two anticancer drugs. Analysis of 38 hMLH1 missense mutations showed that the majority of mutations caused significant (>50%) reductions in their interaction with hMRE11, suggesting a potential link between aberrant protein interaction and the pathogenic effects of hMLH1 variants.

Original languageEnglish (US)
Pages (from-to)338-343
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume370
Issue number2
DOIs
StatePublished - May 30 2008

Fingerprint

Mutation
Missense Mutation
Cisplatin
Assays
Peptides
Pharmaceutical Preparations
Proteins
In Vitro Techniques

Keywords

  • Cisplatin
  • G2/M checkpoint
  • hMLH1
  • hMRE11
  • MMR
  • MNU

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

The interplay between hMLH1 and hMRE11 : Role in MMR and the effect of hMLH1 mutations. / Zhao, Nianxi; Zhu, Fengxue; Yuan, Fenghua; Haick, Anoria K.; Fukushige, Shinichi; Gu, Liya; Her, Chengtao.

In: Biochemical and Biophysical Research Communications, Vol. 370, No. 2, 30.05.2008, p. 338-343.

Research output: Contribution to journalArticle

Zhao, Nianxi ; Zhu, Fengxue ; Yuan, Fenghua ; Haick, Anoria K. ; Fukushige, Shinichi ; Gu, Liya ; Her, Chengtao. / The interplay between hMLH1 and hMRE11 : Role in MMR and the effect of hMLH1 mutations. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 370, No. 2. pp. 338-343.
@article{38770925b9964684ab5e29cee6a22387,
title = "The interplay between hMLH1 and hMRE11: Role in MMR and the effect of hMLH1 mutations",
abstract = "Our previous studies indicate that hMRE11 plays a role in MMR, and this function of hMRE11 is most likely mediated by the hMLH1-hMRE11 interaction. Here, we explored the functional implications of the hMLH1-hMRE11 interaction in MMR and the effects of hMLH1 mutations on their interaction. Our in vitro MMR assay demonstrated that the dominant-negative hMRE11452-634 mutant peptide (i.e., harboring only the hMLH1-interacting domain) imparted a significant reduction in both 3′ excision and 3′-directed MMR activities. Furthermore, the expression of hMRE11452-634, and to a lesser extent hMRE111-634 (ATLD1), impaired G2/M checkpoint control in response to MNU and cisplatin treatments, rendering cells resistant to killings by these two anticancer drugs. Analysis of 38 hMLH1 missense mutations showed that the majority of mutations caused significant (>50{\%}) reductions in their interaction with hMRE11, suggesting a potential link between aberrant protein interaction and the pathogenic effects of hMLH1 variants.",
keywords = "Cisplatin, G2/M checkpoint, hMLH1, hMRE11, MMR, MNU",
author = "Nianxi Zhao and Fengxue Zhu and Fenghua Yuan and Haick, {Anoria K.} and Shinichi Fukushige and Liya Gu and Chengtao Her",
year = "2008",
month = "5",
day = "30",
doi = "10.1016/j.bbrc.2008.03.082",
language = "English (US)",
volume = "370",
pages = "338--343",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The interplay between hMLH1 and hMRE11

T2 - Role in MMR and the effect of hMLH1 mutations

AU - Zhao, Nianxi

AU - Zhu, Fengxue

AU - Yuan, Fenghua

AU - Haick, Anoria K.

AU - Fukushige, Shinichi

AU - Gu, Liya

AU - Her, Chengtao

PY - 2008/5/30

Y1 - 2008/5/30

N2 - Our previous studies indicate that hMRE11 plays a role in MMR, and this function of hMRE11 is most likely mediated by the hMLH1-hMRE11 interaction. Here, we explored the functional implications of the hMLH1-hMRE11 interaction in MMR and the effects of hMLH1 mutations on their interaction. Our in vitro MMR assay demonstrated that the dominant-negative hMRE11452-634 mutant peptide (i.e., harboring only the hMLH1-interacting domain) imparted a significant reduction in both 3′ excision and 3′-directed MMR activities. Furthermore, the expression of hMRE11452-634, and to a lesser extent hMRE111-634 (ATLD1), impaired G2/M checkpoint control in response to MNU and cisplatin treatments, rendering cells resistant to killings by these two anticancer drugs. Analysis of 38 hMLH1 missense mutations showed that the majority of mutations caused significant (>50%) reductions in their interaction with hMRE11, suggesting a potential link between aberrant protein interaction and the pathogenic effects of hMLH1 variants.

AB - Our previous studies indicate that hMRE11 plays a role in MMR, and this function of hMRE11 is most likely mediated by the hMLH1-hMRE11 interaction. Here, we explored the functional implications of the hMLH1-hMRE11 interaction in MMR and the effects of hMLH1 mutations on their interaction. Our in vitro MMR assay demonstrated that the dominant-negative hMRE11452-634 mutant peptide (i.e., harboring only the hMLH1-interacting domain) imparted a significant reduction in both 3′ excision and 3′-directed MMR activities. Furthermore, the expression of hMRE11452-634, and to a lesser extent hMRE111-634 (ATLD1), impaired G2/M checkpoint control in response to MNU and cisplatin treatments, rendering cells resistant to killings by these two anticancer drugs. Analysis of 38 hMLH1 missense mutations showed that the majority of mutations caused significant (>50%) reductions in their interaction with hMRE11, suggesting a potential link between aberrant protein interaction and the pathogenic effects of hMLH1 variants.

KW - Cisplatin

KW - G2/M checkpoint

KW - hMLH1

KW - hMRE11

KW - MMR

KW - MNU

UR - http://www.scopus.com/inward/record.url?scp=42249086268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249086268&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.03.082

DO - 10.1016/j.bbrc.2008.03.082

M3 - Article

C2 - 18373977

AN - SCOPUS:42249086268

VL - 370

SP - 338

EP - 343

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -